Dr. Shawn Ritchie, on behalf of MLD and our collaborators at Rush University, will be presenting at DDW in Washington DC on June 3, 2018. Our presentation highlights recent results connecting GTA fatty acid deficiency, a known risk factor for colorectal cancer, to specific gut microbes. The findings represent the first steps towards a GTA replacement therapeutic strategy for treating colorectal and pancreatic cancer through the modulation of gastrointestinal inflammatory risk.